Mirrakhimov E 1
1. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
2. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
4. Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study
5. Cardiovascular Disease Burden in Rural Central Asia: A Systematic Review of Epidemiological Trends and Mortality Patterns
6. Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis
7. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE v survey in 16 European countries
8. The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study
9. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017
10. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
11. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
12. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
13. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
14. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
15. Diminishing benefits of urban living for children and adolescents’ growth and development
16. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
17. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study
18. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
19. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)
20. 2025 ESC Guidelines for the management of myocarditis and pericarditis
21. Insights into the European heart failure epidemiology
22. The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019
23. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: Results from ropac (registry of pregnancy and cardiac disease) of the european society of cardiology eurobservational research programme
24. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
25. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
26. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1